Cowen Prime Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-40
Closed -$1K 231
2023
Q1
$1K Hold
40
﹤0.01% 223
2022
Q4
$1K Hold
40
﹤0.01% 190
2022
Q3
$1K Hold
40
﹤0.01% 173
2022
Q2
$1K Hold
40
﹤0.01% 177
2022
Q1
$1K Hold
40
﹤0.01% 177
2021
Q4
$1K Hold
40
﹤0.01% 173
2021
Q3
$1K Hold
40
﹤0.01% 169
2021
Q2
$1K Buy
+40
New +$1.32K ﹤0.01% 166

Other funds holding OGN

Cowen Prime Advisors's OGN Position: Q2 2023 in Review

Cowen Prime Advisors sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 40 shares — an estimated $1K sold.

Cowen Prime Advisors first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $1K in Q1 2023. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • Cowen Prime Advisors reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • Cowen Prime Advisors sold 40 Organon & Co shares in Q2 2023, an estimated $1K.
  • Cowen Prime Advisors first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Cowen Prime Advisors's Organon & Co position peaked at $1K in Q1 2023.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.